Concepedia

Miroslav Veith

MV

Statistics

Publications

11

Citations

535

H-Index

11

Active since

2019

Affiliations

University Hospital Kralovske Vinohrady(Current)

University Hospital Hradec Králové

Charles University

Bajcsy-Zsilinszky Kórház és Rendelőintézet

University of Debrecen

Miroslav Veith is an author at University Hospital Kralovske Vinohrady specializing in ophthalmology, medicine, and macular disease.

ORCID

Publications per year

2019–2024

11

Publications

11

Faricimab Treat-and-Extend for Diabetic Macular Edema

Tien Yin Wong, Zdenka Hašková, Kemal Asik et al. · Ophthalmology · 2023 · 138 citations · Full text

, , +9

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

David M. Brown, David S. Boyer, V. Diana et al. · The Lancet · 2024 · 113 citations

, , +10

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration

Se Joon Woo, Miroslav Veith, Jan Hamouz et al. · JAMA Ophthalmology · 2020 · 81 citations · Full text

, , +15

Early disruption of photoreceptor cell architecture and loss of vision in a humanized pig model of usher syndromes

Sophia Grotz, Jessica Schäfer, Kirsten A. Wunderlich et al. · EMBO Molecular Medicine · 2022 · 45 citations · Full text

, , +17

Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes

Neil M. Bressler, Miroslav Veith, Jan Hamouz et al. · British Journal of Ophthalmology · 2021 · 44 citations · Full text

, , +16

1–5 of 11